Company Data
NeuroSense Therapeutics Ltd.
Ticker
NRSN
Current Price
$1.1 -2.65%
Market Cap
$21.4M
Price Target
Refer to Report
Volume
100.0K
52wk Range
$0.512 - $2.33
Overview
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer’s disease and Parkinson’s disease, among others. Its lead product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.